Diagnostic Criteria and Imaging Techniques in Multiple Sclerosis

Multiple sclerosis is a chronic inflammatory disorder of the central nervous system characterised by demyelination, neuroaxonal loss and gliosis. Accurate and timely diagnosis rests on clinical evaluation supported by magnetic resonance imaging and cerebrospinal fluid analysis. The McDonald criteria, first introduced in 2001 and revised most recently in 2017, standardise the demonstration of lesions disseminated in space and time. Conventional MRI sequences—T2-weighted imaging for lesion detection and T1-weighted imaging with gadolinium for active inflammation—remain the cornerstone of diagnosis and monitoring. Advanced MRI methods, including diffusion tensor imaging and magnetisation transfer techniques, provide quantitative markers of microstructural injury and myelin integrity. Ultrahigh-field MRI at 7-Tesla has further enhanced the visualisation of cortical and small-vessel lesions. Complementary modalities such as optical coherence tomography allow non-invasive assessment of retinal nerve fibre layer thinning, reflecting global neurodegeneration. Emerging molecular imaging with myelin-binding tracers and automated lesion segmentation using artificial intelligence offer promise for personalised prognosis and therapeutic response monitoring. Together, these diagnostic criteria and imaging advances underpin earlier detection, improved differential diagnosis and more precise tracking of disease evolution in multiple sclerosis.

Research from Nature Portfolio

Recent studies have employed ultrahigh-field magnetic resonance imaging at 7-Tesla to resolve cortical lesions previously undetectable at lower field strengths. These high-resolution images reveal distinct patterns of intracortical and leukocortical demyelination that correlate with cognitive impairment and progressive clinical subtypes, offering refined stratification of patients for targeted interventions.

Innovations in molecular imaging have introduced positron emission tomography tracers selective for myelin sheaths. In vivo studies demonstrate that these tracers quantitatively map demyelination and remyelination dynamics, enabling direct measurement of treatment-induced myelin repair in clinical trials. This approach heralds a shift towards biomarker-guided therapies aimed at promoting remyelination.

Artificial intelligence algorithms trained on large multimodal MRI datasets now automate the segmentation of white-matter and cortical lesions with high accuracy. These tools standardise lesion load quantification across centres and reduce observer bias, facilitating real-world implementation of harmonised imaging biomarkers for disease activity and progression.

Diagnostic Criteria and Imaging Techniques in Multiple Sclerosis publication trend

The graph below shows the total number of articles in diagnostic criteria and imaging techniques in multiple sclerosis across all publications each year (not limited to Nature Index journals).

Technical terms

McDonald criteria: Diagnostic guidelines for multiple sclerosis requiring evidence of lesions disseminated in space and time.

Dissemination in space: Presence of lesions in multiple distinct regions of the central nervous system.

Dissemination in time: Occurrence of new lesions or active enhancement on MRI at different time points.

Oligoclonal bands: Bands of immunoglobulin G in cerebrospinal fluid indicating intrathecal antibody synthesis.

Diffusion tensor imaging: MRI technique measuring directional water diffusion to assess neural microstructure.

Magnetisation transfer ratio: MRI metric sensitive to macromolecular content, particularly myelin density.

Optical coherence tomography: Non-invasive imaging of the retina to quantify retinal nerve fibre layer thickness as a marker of neuroaxonal loss.

References

1. Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis. Frontiers in Neurology (2019).